Startup Reaches $1 Billion Valuation Processing Prescription Drug Paperwork With AI

The company noted that specialty drugs for cancers and autoimmune diseases often cost thousands or hundreds of thousands of dollars. These therapies typically require processing through specialty pharmacies and additional approval layers. The software addresses those administrative steps.

The company works primarily with pharmaceutical manufacturers rather than charging doctors or patients. It has partnerships with half of the top 10 global pharmaceutical companies as well as several fast-growing startups. The company is supporting several large drug launches this year by handling insurance processing and ensuring pharmacy stock levels.

Prescription drug spending is expected to surpass $1 trillion this year according to a report from the American Society of Health-System Pharmacists. That would leave more than $300 billion in therapies unfilled. One executive who previously led a major pharmaceutical company said that nearly 50 percent of prescriptions were not adhered to and 35 percent of new scripts went unfilled while he was in that role.

About four in 10 U.S. adults reported not taking medication as prescribed in the past year due to costs according to a recent KFF poll. Larger shares among lower-income, uninsured, women, Black and Hispanic adults said they took measures such as switching to over-the-counter drugs or splitting pills.

Taking medications as prescribed can reduce broader healthcare costs by preventing serious complications that lead to emergency care or surgery. The founder stated that too few eligible patients receive treatment even when drugs reach the market. The company positions its technology as addressing the last-mile problem in getting approved therapies to patients.